Rolf Larsson

发表

Geofysik i släntstabilitetsutredningar

Torleif Dahlin, Rolf Larsson, Virginie Leroux, 2001 .

Advanced Surface Modifications for Blood-Contacting Surfaces of Medical Devices

Rolf Larsson, Zhongjun J. Wu, Narayana Garimella, 2012, International journal of biomaterials.

Sprutboxarbetsplatsen - en miljö som kan och bör förbättras

Roland Akselsson, Rolf Larsson, Eric von Gertten, 1981 .

3RIP: File Design for the Search System.

Rolf Larsson, 1975 .

Robust supply-chain management for the disasters : Based on the product design architectures

Rolf Larsson, Yasuhiro Monden, 2014 .

New use in the Transplantationsschirugie

Rolf Larsson, William Bennet, Olle Korsgren, 2000 .

Framtidens ledningssystem för skola och förskola

Rolf Larsson, Sten-Bertil G Olsson, R. Larsson, 2012 .

Brunn: An open source laboratory information system for microplates with a graphical plate layout design process

Ola Spjuth, Jonathan Alvarsson, Jarl E. S. Wikberg, 2011, BMC Bioinformatics.

Testing for Unit Root Against Stationarity Using the Likelihood Ratio Test

Rolf Larsson, Nikolay Angelov, 2007, Commun. Stat. Simul. Comput..

Värdecirkeln. Hur utvecklar IKEA och Volvo långsiktig konkurrenskraft.

Göran Andersson, Rolf Larsson, 2008 .

Testing for INAR effects

Rolf Larsson, Rolf Larsson, 2020, Commun. Stat. Simul. Comput..

In Vitro Drug Sensitivity-Gene Expression Correlations Involve a Tissue of Origin Dependency

Mårten Fryknäs, Rolf Larsson, Mats G. Gustafsson, 2007, J. Chem. Inf. Model..

Pastime--A System for File Compression.

Rolf Larsson, Jan Hultgren, 1975 .

A Method Defining a Limited Set of Character-Strings with Maximal Coverage of a Sample of Text.

Rolf Larsson, Jan Hultgren, 1973 .

A likelihood ratio type test for invertibility in moving average processes

Rolf Larsson, 2014, Comput. Stat. Data Anal..

3RIP Version 4.0 (Including the EURONET Common Command Language).

Rolf Larsson, Jan Sunneback, 1981 .

Discrete factor analysis using a dependent Poisson model

Rolf Larsson, 2020, Comput. Stat..

The Fluorometric Microculture Cytotoxicity Assay. Nat Protoc 3:1364

Elin Lindhagen, Rolf Larsson, Peter Nygren, 2008 .

Inhibition of proteasome deubiquitinating activity as a new cancer therapy

Mårten Fryknäs, Rolf Larsson, Moustapha Hassan, 2011, Nature Medicine.

Inhibition of proteasome activity, nuclear factor‐KB translocation and cell survival by the antialcoholism drug disulfiram

Rolf Larsson, Peter Nygren, Linda Rickardson, 2006 .

Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer

Mårten Fryknäs, Rolf Larsson, Peter Nygren, 2015, Molecular Cancer Therapeutics.

A New Antibody Recognizing the vIII Mutation of Human Epidermal Growth Factor Receptor

Rolf Larsson, Torgny Stigbrand, Kenneth Wester, 2002, Tumor Biology.

Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.

Mårten Fryknäs, Rolf Larsson, Mia Niklasson, 2016, Cell reports.

Label free high throughput screening for apoptosis inducing chemicals using time-lapse microscopy signal processing

Mårten Fryknäs, Rolf Larsson, Mats G. Gustafsson, 2014, Apoptosis.

Label free quantification of time evolving morphologies using time-lapse video microscopy enables identity control of cell lines and discovery of chemically induced differential activity in iso-genic cell line pairs

Saadia Bashir Hassan, Mårten Fryknäs, Rolf Larsson, 2015 .

DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia

Rolf Larsson, Johan Dahlberg, Mats G Gustafsson, 2014, Clinical Epigenetics.

Detection of Cell Aggregation and Altered Cell Viability by Automated Label-Free Video Microscopy

Mårten Fryknäs, Rolf Larsson, Ulf Hammerling, 2015, Journal of biomolecular screening.

The fluorometric microculture cytotoxicity assay

Elin Lindhagen, Rolf Larsson, Peter Nygren, 2008, Nature Protocols.

Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions

Ola Spjuth, Rolf Larsson, Ulf Hammerling, 2017, Metabolomics.

Towards high‐throughput single cell/clone cultivation and analysis

Rolf Larsson, Sara Lindström, S. Lindström, 2008, Electrophoresis.

Effects of hypoxia on human cancer cell line chemosensitivity

Mårten Fryknäs, Rolf Larsson, Sara Strese, 2013, BMC Cancer.

Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy

Jonathan Alvarsson, Rolf Larsson, Claes R. Andersson, 2016, Journal of laboratory automation.

Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828.

Rolf Larsson, Peter Nygren, R. Larsson, 2004, Molecular cancer therapeutics.

Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma

Mårten Fryknäs, Rolf Larsson, Linda Rickardson, 2012, BMC Cancer.

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer

Mårten Fryknäs, Rolf Larsson, Peter Nygren, 2013, Journal of Cancer Research and Clinical Oncology.

Label-free detection and dynamic monitoring of drug-induced intracellular vesicle formation enabled using a 2-dimensional matched filter

Mårten Fryknäs, Rolf Larsson, Ulf Hammerling, 2014, Autophagy.

A Phase I study of CHS 828 in patients with solid tumor malignancy.

Rolf Larsson, Mats O Karlsson, Johan Ahlgren, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Mårten Fryknäs, Rolf Larsson, Efthymia Chantzi, 2017, Leukemia research.

Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients.

Anders Isaksson, Rolf Larsson, Peter Nygren, 2007, Biochemical pharmacology.

Modeling of In Vitro Drug Activity and Prediction of Clinical Outcome in Acute Myeloid Leukemia

Elin Lindhagen, Rolf Larsson, Mats O Karlsson, 2007, Journal of clinical pharmacology.

Iron chelators target both proliferating and quiescent cancer cells

Mårten Fryknäs, Rolf Larsson, Ingmar Persson, 2016, Scientific Reports.

In vitro and in vivo activity of melflufen (J1)in lymphoma

Rolf Larsson, Sara Strese, R. Larsson, 2016, BMC Cancer.

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism

Rolf Larsson, Mats G. Gustafsson, Peter Nygren, 2017, Oncotarget.

ChemGPS‐NP Mapping of Chemical Compounds for Prediction of Anticancer Mode of Action

Rolf Larsson, Lars Bohlin, Johan Gottfries, 2009 .